Company intelligence / Profile preview
Bio-STILOGIT Pharmaceuticals
- Ownership
- Private
- Development stage
- Other
Overview
Bio-STILOGIT is an Italian pharmaceutical company specializing in the research, development, and commercialization of innovative ophthalmic and dermatological products. The company focuses on addressing complex ocular pathologies such as diabetic retinopathy, macular degeneration, and dry eye syndrome through advanced formulations that target oxidative stress and inflammatory pathways. Bio-STILOGIT maintains a robust portfolio of medical devices and food supplements designed to support eye health and prevent vision loss. By leveraging collaborations with academic institutions and clinical centers, the company translates biochemical research into practical therapeutic solutions for specialists and patients.
- Therapeutic areas
- Ophthalmology
- Modalities
- Small moleculePeptidesTopical formulation
- Industry
- Biotech
Drug pipeline
8 assets7 more assets in the full pipeline.
Beyond the preview
Go deeper on Bio-STILOGIT Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bio-STILOGIT Pharmaceuticals.